Santhera Pharmaceuticals Holding AG
OTC:SPHDF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Santhera Pharmaceuticals Holding AG
OTC:SPHDF
|
CH |
|
L
|
Lumentum Holdings Inc
XETRA:LU2
|
US |
|
D
|
DSV A/S
DUS:DS81
|
DK |
|
Legrand SA
F:LRC0
|
FR |
|
P
|
Publicis Groupe SA
OTC:PGPEF
|
FR |
Wall St Price Targets
SPHDF Price Targets Summary
Santhera Pharmaceuticals Holding AG
According to Wall Street analysts, the average 1-year price target for SPHDF is 40.76 USD with a low forecast of 36.69 USD and a high forecast of 45.77 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is SPHDF's stock price target?
Price Target
40.76
USD
According to Wall Street analysts, the average 1-year price target for SPHDF is 40.76 USD with a low forecast of 36.69 USD and a high forecast of 45.77 USD.
What is the Revenue forecast for Santhera Pharmaceuticals Holding AG?
Projected CAGR
49%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 3 years is 49%.
What is the Gross Profit forecast for Santhera Pharmaceuticals Holding AG?
Projected CAGR
-19%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 17%. The projected CAGR for the next 4 years is -19%.
